Applications open for consultation

Filter results

You can narrow down the results using the filters

Results

Displaying 1 - 13 of 13 results

1762 – Amendment to HER-2 MBS item to allow for trastuzumab deruxtecan for the treatment of patients with metastatic gastric or gastroesophageal junction adenocarcinoma

Application type:

New application

Consultation:

Open
1791 – Dinutuximab beta for primary relapse and refractory high-risk neuroblastoma

Application type:

Re-application

Consultation:

Open
1555.1 – Endoscopic sleeve gastroplasty for the treatment of patients with Class I and II obesity who have failed first line (lifestyle modification) and second line (pharmacotherapy) treatments

Application type:

Re-application

Consultation:

Open
1782 – Genetic testing to detect estrogen receptor 1 (ESR1) variants in patients with estrogen receptor (ER)-positive, HER2-negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised elacestrant

Application type:

New application

Consultation:

Open
1708.1 – Hepatitis delta virus (HDV) RNA PCR testing to determine eligibility for PBS-subsidised bulevirtide (HEPCLUDEX) for treatment of HDV

Application type:

Re-application

Consultation:

Open
1769 – Human leukocyte antigen (HLA) testing for hypersensitivity to carbamazepine and oxcarbazepine

Application type:

New application

Consultation:

Open
1767 – Immunohistochemistry testing for Claudin 18 expression in patients with gastric or gastro-oesophageal junction cancers, to determine eligibility for PBS subsidised zolbetuximab treatment

Application type:

New application

Consultation:

Open
1774 – Newborn bloodspot screening for glycogen storage disease, Type II (GSD II; Pompe disease)

Application type:

New application

Consultation:

Open
1776 – Newborn bloodspot screening for mucopolysaccharidosis Type II (MPS II; Hunter syndrome)

Application type:

New application

Consultation:

Open
1754 – Surgical Procedures for Gender Affirmation in Adults with Gender Incongruence

Application type:

New application

Consultation:

Open
1657.1 – Rhenium-188 brachytherapy for non-melanoma skin cancer

Application type:

Re-application

Consultation:

Open
1772 – Single chamber leadless pacing with atrio-ventricular synchronous pacing in patients with bradycardia

Application type:

New application

Consultation:

Open
1779 – Testing of tumour tissue to detect FGFR2 fusions or rearrangements in people with cholangiocarcinoma, to determine eligibility for treatment with PBS subsidised futibatinib

Application type:

New application

Consultation:

Open

Sub menu

Applications open for consultation

Filter results

Pre-MSAC consultation status

Pre-PASC consultation status

Results

1762 – Amendment to HER-2 MBS item to allow for trastuzumab deruxtecan for the treatment of patients with metastatic gastric or gastroesophageal junction adenocarcinoma

1791 – Dinutuximab beta for primary relapse and refractory high-risk neuroblastoma

1555.1 – Endoscopic sleeve gastroplasty for the treatment of patients with Class I and II obesity who have failed first line (lifestyle modification) and second line (pharmacotherapy) treatments

1782 – Genetic testing to detect estrogen receptor 1 (ESR1) variants in patients with estrogen receptor (ER)-positive, HER2-negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised elacestrant

1708.1 – Hepatitis delta virus (HDV) RNA PCR testing to determine eligibility for PBS-subsidised bulevirtide (HEPCLUDEX) for treatment of HDV

1769 – Human leukocyte antigen (HLA) testing for hypersensitivity to carbamazepine and oxcarbazepine

1767 – Immunohistochemistry testing for Claudin 18 expression in patients with gastric or gastro-oesophageal junction cancers, to determine eligibility for PBS subsidised zolbetuximab treatment

1774 – Newborn bloodspot screening for glycogen storage disease, Type II (GSD II; Pompe disease)

1776 – Newborn bloodspot screening for mucopolysaccharidosis Type II (MPS II; Hunter syndrome)

1754 – Surgical Procedures for Gender Affirmation in Adults with Gender Incongruence

1657.1 – Rhenium-188 brachytherapy for non-melanoma skin cancer

1772 – Single chamber leadless pacing with atrio-ventricular synchronous pacing in patients with bradycardia

1779 – Testing of tumour tissue to detect FGFR2 fusions or rearrangements in people with cholangiocarcinoma, to determine eligibility for treatment with PBS subsidised futibatinib

Help us improve